Published data revealed that Sirt3 was implicated in tumor progress[15,16], mainly through mediating the suppression of hypoxia inducible factor 1α (HIF-1α) and inhibiting mitochondrial ROS production[17,18]. Here, SIRT3 is linked to neoplasm.